Sign in

CIK 0001645460 · Non-accelerated filer<br>Smaller reporting company

Cue Biopharma, Inc.

Sign in to watch
Ticker
CUE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
473324577
Phone
617-949-2680
Business address
100 CHESTNUT STREET, SUITE 300, SOMERVILLE, MA, 02143
Former names
Imagen Biopharma, Inc.
  1. 4 Open-market sale Chief Legal Compliance Officer sold 1,844 shares at $28.05 ($51,724)
  2. 4 Open-market sale VP, Prin. Accounting Officer sold 1,144 shares at $28.05 ($32,089)
  3. 4 Open-market sale Chief Executive Officer sold 11,087 shares at an average $27.55 ($305,490)
  4. 4/A Grant or award Director acquired 18,400 shares (grant or award)
  5. 4/A Grant or award Director acquired 18,900 shares (grant or award)
  6. 4 Open-market sale Chief Legal Compliance Officer sold 8,829 shares at an average $30.09 ($265,628)
  7. 4 Open-market sale VP, Prin. Accounting Officer sold 5,628 shares at an average $30.09 ($169,324)
  8. 4 Open-market sale Chief Executive Officer sold 58,258 shares at an average $27.58 ($1,606,562)
  9. 4 Grant or award Chief Financial Officer acquired 25,500 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4/A Derivatives Options or other derivatives
  12. 4 Grant or award Chief Medical Officer acquired 31,500 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Grant or award Director acquired 21,800 shares (grant or award)
  15. 4 Grant or award Director acquired 21,800 shares (grant or award)
  16. 4 Grant or award Director acquired 21,800 shares (grant or award)
  17. 4 Grant or award Director acquired 21,800 shares (grant or award)
  18. 4 Grant or award VP, Prin. Accounting Officer acquired 40,942 shares (grant or award)
  19. 4 Grant or award Chief Legal Compliance Officer acquired 54,589 shares (grant or award)
  20. 4 Grant or award Chief Executive Officer acquired 327,537 shares (grant or award)

Page 1 of 13 · 259 filings